Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
archive
boston
boston blog main
boston top stories
fda
life sciences
medical
national blog main
national top stories
postpartum depression
sage therapeutics
allopregnanolone
biotech
brexanalone
brexanolone
clinical data
clinical trials
depression
drugs
government
healthcare
jeff jonas
major depressive disorder
marc goodman
marinus pharmaceuticals
medicine
mental illness
mike cloonan
neuroscience
new york blog main
new york top stories
phase 3 trial
psychiatric disorders
research
steven kanes
svb leerink
zulresso
What
depression
4
×
drug
4
×
fda
4
×
approved
disorder
treatment
administration
approval
bit
breakthrough
brexanalone
brexanolone
called
company
compound
designation
devastating
esketamine
fast
food
gets
granted
hits
hour
infusion
investigation
major
mark
mdd
med
medical
medication
medicine
million
moms
mus
nasal
new
oks
partum
Language
unset
Current search:
fda
×
depression
×
drug
×
@slashgear.com
4 years ago
Another company gets FDA designation to treat depression with psilocybin
@slashgear.com
5 years ago
This nasal spray stops med-resistant depression in trials
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
Sage Hits Mark in Postpartum Depression Phase 3 Trial, Stock Surges